West Pharmaceutical Services Finance Lease Liabilities decreased by 8.3% to $3.30M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 6.5%, from $3.10M to $3.30M. This is a positive signal — lower values indicate better performance for this metric.
High levels indicate significant reliance on leased assets for operations, which serves as a form of off-balance-sheet-style financing.
This represents the total long-term obligations under finance leases, excluding the current portion. It reflects the com...
Used to compare capital intensity and financing strategies across peers.
finance_lease_liabilities| Q4 '21 | Q4 '22 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $2.40M | $2.20M | $2.10M | $3.10M | $3.60M | $3.90M | $3.60M | $3.30M |
| QoQ Change | — | — | — | -8.3% | -4.5% | +47.6% | +16.1% | +8.3% | -7.7% | -8.3% |
| YoY Change | — | — | — | — | — | — | +50.0% | +77.3% | +71.4% | +6.5% |